These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 18056453)
1. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta. Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells. Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421 [TBL] [Abstract][Full Text] [Related]
3. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924 [TBL] [Abstract][Full Text] [Related]
4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Zhang M; Zou Z; Maass N; Sager R Cancer Res; 1995 Jun; 55(12):2537-41. PubMed ID: 7780965 [TBL] [Abstract][Full Text] [Related]
6. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells. Kijima I; Ye J; Glackin C; Chen S Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer. Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211 [TBL] [Abstract][Full Text] [Related]
8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418 [TBL] [Abstract][Full Text] [Related]
10. Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription. Niehof M; Kubicka S; Zender L; Manns MP; Trautwein C J Mol Biol; 2001 Jun; 309(4):855-68. PubMed ID: 11399064 [TBL] [Abstract][Full Text] [Related]
11. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. Eaton EM; Hanlon M; Bundy L; Sealy L J Cell Physiol; 2001 Oct; 189(1):91-105. PubMed ID: 11573208 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Freund A; Jolivel V; Durand S; Kersual N; Chalbos D; Chavey C; Vignon F; Lazennec G Oncogene; 2004 Aug; 23(36):6105-14. PubMed ID: 15208657 [TBL] [Abstract][Full Text] [Related]
13. Re-expression of elafin in 21MT2 breast carcinomas by phorbol 12-myristate 13-acetate is mediated by the Ap1 site in the elafin promoter. Zhang M; Magit D; Pardee AB; Sager R Cancer Res; 1997 Oct; 57(20):4631-6. PubMed ID: 9377579 [TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer binding protein-beta (C/EBP-beta), a pivotal regulator of the TATA-less promoter in the rat catalase gene. Taniguchi M; Hashimoto M; Hori N; Sato K FEBS Lett; 2005 Oct; 579(25):5785-90. PubMed ID: 16223488 [TBL] [Abstract][Full Text] [Related]
15. AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. Madireddi MT; Dent P; Fisher PB J Cell Physiol; 2000 Oct; 185(1):36-46. PubMed ID: 10942517 [TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Antonova L; Mueller CR Genes Chromosomes Cancer; 2008 Apr; 47(4):341-52. PubMed ID: 18196591 [TBL] [Abstract][Full Text] [Related]
17. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker. Tomizawa M; Watanabe K; Saisho H; Nakagawara A; Tagawa M Anticancer Res; 2003; 23(1A):351-4. PubMed ID: 12680236 [TBL] [Abstract][Full Text] [Related]
18. Insulin-dependent leptin expression in breast cancer cells. Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation. Ling G; Wei Y; Ding X Mol Pharmacol; 2007 Mar; 71(3):807-16. PubMed ID: 17148654 [TBL] [Abstract][Full Text] [Related]
20. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. Li H; Weinstein IB Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]